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Supplemental Data
Supplementary Figure S1 . Literature overview of infarct size reduction after helium preconditioning. Summary of literature in which infarct sizes are plotted as a percentage of area at risk after helium preconditioning. Data are plotted as means. At the bottom of the figure an overview of the absolute infarct size reduction is given. Infarct size reduction by early preconditioning (EPC) entails application of 5-min cycles of helium inhalation before the ischemic episode. EPC1, EPC3 and EPC5 consist of 1, 3 or 5 5-min cycles of helium before ischemia, respectively. Late preconditioning (LPC) is based on 15 min of helium administration 24 h before the ischemic episode and also results in infarct size reduction. Rat experiments: 25 min of ischemia and 2 h of reperfusion, rabbit experiments 30 min of ischemia and 3 h of reperfusion. A (1): n=8 per group, EPC3; B (2): n=8 per group, EPC3; C (3): n=10 per group, EPC3; D (4): n=8-12 per group, LPC; E (5): n=6 per group, EPC3; F (6): n=6/7 per group, EPC3, EPC1; D (7): n=7/8 per group, EPC3; G (8): n=6/7 per group, EPC5, EPC3, EPC1; H (9): n=8 per group, EPC3; I (10): n=8 per group, EPC3.
Supplementary Figure S2 . Preparation of histological slices. Hearts were cut in two parts, crossing the previous ligation of the LAD. RNA was extracted from heart tissue using the RNAeasy Fibrous Tissue Mini Kit (Qiagen, Venlo, The Netherlands) according to manufacturer's instructions. All materials and reagents used in the procedure were from Qiagen, unless stated otherwise. In brief, ±30 mg of heart tissue was added to 300 μL of RLT lysis buffer containing 1% (v/v) β-mercaptoethanol and homogenized with a MagNA Lyser using MagNA Lyser Green Beads (both from Roche Applied Sciences, Penzberg, Germany). The lysate was collected and 600 μL of nuclease-free water containing 1.67% (v/v) proteinase K was added to digest residual fibrous tissue (6 min at 55 o C). Total RNA was extracted using spin columns, including on-column DNAse I treatment, and eluted in 30 μL of nuclease-free water. Next, eluate RNA concentrations were determined by UV-vis absorbance spectroscopy (NanoDrop, Thermo Scientific, Rockford IL). RNA yields typically ranged from 0.3 to 3 μg/μL (data not shown). To ensure RNA purity, samples with an A260/A280 ratio of ≤1.99 were excluded from further analysis. Next, 1 μg of RNA was reverse transcribed to cDNA. using the RT 2 First Strand Kit according to manufacturer's instructions. RNA was reverse transcribed to cDNA using the RT 2 First Strand Kit (Qiagen, catalogue number #330401) according to manufacturer's instructions. Before starting the procedure, the RNA concentration of all samples was diluted to 250 ng/μL with nuclease-free water. Next, 1 μg (4 μL) of RNA was mixed with 2 μL of GE-buffer and 2 μL of nuclease-free water and incubated at 42 
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METHODS: WESTERN BLOT ANALYSIS Preparation of Cytosol, Membrane and Mitochondrial fractions
Excised hearts were shock-frozen in liquid nitrogen and pulverized in a precooled mortar. Samples were dissolved in lysis buffer containing Tris base, EGTA, NaF and Na 3 VO 4 (as phosphatase inhibitors), an inase-inhibitor mix (aprotinin, leupetin and Pepsatin), DTT and okadaic acid. The solution was homogenized on ice (Homogenisator, Ultra-Turrax T8) and centrifuged slowly at 1000 g, 4°C for 10 min. The remaining supernatant was pipetted in new vials and centrifuged at 10000 g, from which a pellet remained containing the mitochondria. The supernatant was re-centrifuged at 12000 g to obtain a cytosolic fraction. The remaining pellet was sus- pended in lysis buffer (containing 1% Triton X-100), incubated for 60 min on ice and vortexed. The solution was centrifuged at 16000 g for 15 min, resulting in a supernatant containing the membrane fraction. All fractions were stored at -80°C.
Western Blot Analysis
After protein determination by the Bradford method (14), equal amounts of protein were mixed with sample buffer (containing SDS, Bromophenol Blue,Tris Base, Glycerol and Mercaptoethanol). Samples were vortexed, boiled at 95°C for 5 min, and loaded on a Criterion Gel. Proteins were separated by electrophoresis and transferred onto Immobilin-FL Membrane. Unspecific binding of the antibody was blocked by incubation with Odyssey ® Blocking Buffer for 60 min. 
